Featured Articles

31. Achieve Higher Targeted Concentrations 9/30/2025

    Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.

32. Effective Supply Chain And QC Testing Through Collaborative Partnerships 9/30/2025

    Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.

33. Considerations In Sterility Testing And Assurance 9/23/2025

    Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety.

34. Cell Culture Media Fingerprinting 9/8/2025

    Ensure consistency and quality in production with an advanced CCM fingerprinting technique that is capable of identifying over 100 media components to reduce variability and meet regulatory standards.

35. How To Fingerprint Cell Culture Media 9/8/2025

    Ensuring media identity and consistency is vital in biologics manufacturing. Discover why quantifying cell culture media components before batch release helps overcome formulation complexity.

36. Managing Endotoxins - Detect, Prevent, Remove 9/8/2025

    Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.

37. Benefits Of Outsourcing To An Integrated CDMO 9/8/2025

    Streamlining ADC development through an integrated CDMO can reduce risk and improve quality. Discover why specialized expertise in linker chemistry and bioconjugation is key to overcoming the complexity of ADC manufacturing.

38. Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection 8/27/2025

    The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.

39. Overcoming Challenges In Ophthalmic Formulations 8/27/2025

    Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.

40. Overcoming Excipient Risks And Challenges For Parenteral Formulations 8/27/2025

    Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.